# FDA Inspection 1252580 - Jeffrey T. Apter, M.D. - October 22, 2024

Source: https://www.keypedia.com/records/fda_inspections/jeffrey-t-apter-md/a57767ff-e521-4951-9331-32ca038bed55
Source feed: FDA_Inspections

> FDA Inspection 1252580 for Jeffrey T. Apter, M.D. on October 22, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1252580
- Company Name: Jeffrey T. Apter, M.D.
- Inspection Date: 2024-10-22
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1252580 - 2024-10-22](https://www.keypedia.com/records/fda_inspections/jeffrey-t-apter-md/4e7fc737-a6d0-4f65-a9cc-e6c65d76adc6)
- [FDA Inspection 1123091 - 2020-03-13](https://www.keypedia.com/records/fda_inspections/jeffrey-t-apter-md/10b9f1f9-ce6c-48cd-aa6e-3ac5429ecea3)

Company: https://www.keypedia.com/companies/jeffrey-t-apter-md/95ebce37-6030-42af-abad-78deb1f256a4

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c